NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dr Pepper Snapple Group, Inc. DPS, United Therapeutics Corporation UTHR, Universal Health Realty Income Trust UHT, Forestar Group Inc. FOR, Schlumberger Limited SLB, and Thermo Fisher Scientific Inc. TMO, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
DPS DOWNLOAD: http://Fundamental-Markets.com/register/?so=DPS
UTHR DOWNLOAD: http://Fundamental-Markets.com/register/?so=UTHR
UHT DOWNLOAD: http://Fundamental-Markets.com/register/?so=UHT
FOR DOWNLOAD: http://Fundamental-Markets.com/register/?so=FOR
SLB DOWNLOAD: http://Fundamental-Markets.com/register/?so=SLB
TMO DOWNLOAD: http://Fundamental-Markets.com/register/?so=TMO
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Dr Pepper Snapple Group, Inc DPS, United Therapeutics Corporation UTHR, Universal Health Realty Income Trust UHT, Forestar Group Inc FOR, Schlumberger Limited SLB, and Thermo Fisher Scientific Inc. TMO on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 21st, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
DR PEPPER SNAPPLE GROUP, INC. (DPS) REPORT OVERVIEW
Dr Pepper Snapple Group's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Dr Pepper Snapple Group reported revenue of $1,594.00MM vs $1,510.00MM (up 5.56%) and basic earnings per share $0.88 vs $0.97 (down 9.28%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Dr Pepper Snapple Group reported revenue of $6,690.00MM vs $6,440.00MM (up 3.88%) and basic earnings per share $5.91 vs $4.57 (up 29.32%). Dr Pepper Snapple Group is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.25. The estimated EPS forecast for the next fiscal year is $5.47 and is expected to report on February 13th, 2019.
To read the full Dr Pepper Snapple Group, Inc. (DPS) report, download it here: http://Fundamental-Markets.com/register/?so=DPS
-----------------------------------------
UNITED THERAPEUTICS CORPORATION (UTHR) REPORT OVERVIEW
United Therapeutics' Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, United Therapeutics reported revenue of $389.20MM vs $370.50MM (up 5.05%) and basic earnings per share $5.65 vs $4.01 (up 40.90%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, United Therapeutics reported revenue of $1,725.30MM vs $1,598.80MM (up 7.91%) and basic earnings per share $9.50 vs $16.29 (down 41.68%). United Therapeutics is expected to report earnings on July 26th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$1.25. The estimated EPS forecast for the next fiscal year is $8.94 and is expected to report on February 20th, 2019.
To read the full United Therapeutics Corporation (UTHR) report, download it here: http://Fundamental-Markets.com/register/?so=UTHR
-----------------------------------------
UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) REPORT OVERVIEW
Universal Health Realty Income Trust's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Universal Health Realty Income Trust reported revenue of $18.54MM vs $17.75MM (up 4.45%) and basic earnings per share $0.70 vs $2.32 (down 69.83%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Universal Health Realty Income Trust reported revenue of $72.35MM vs $67.08MM (up 7.85%) and basic earnings per share $3.35 vs $1.28 (up 161.72%). Universal Health Realty Income Trust is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018.
To read the full Universal Health Realty Income Trust (UHT) report, download it here: http://Fundamental-Markets.com/register/?so=UHT
-----------------------------------------
FORESTAR GROUP INC. (FOR) REPORT OVERVIEW
Forestar Group's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Forestar Group reported revenue of $22.60MM vs $22.31MM (up 1.32%) and basic earnings per share $0.11 vs $0.60 (down 81.67%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Forestar Group reported revenue of $114.32MM vs $197.31MM (down 42.06%) and basic earnings per share $1.19 vs $1.40 (down 15.00%). Forestar Group is expected to report earnings on June 26th, 2018. The report will be for the fiscal period ending March 31st, 2018.
To read the full Forestar Group Inc. (FOR) report, download it here: http://Fundamental-Markets.com/register/?so=FOR
-----------------------------------------
SCHLUMBERGER LIMITED (SLB) REPORT OVERVIEW
Schlumberger's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Schlumberger reported revenue of $7,829.00MM vs $6,894.00MM (up 13.56%) and basic earnings per share $0.38 vs $0.20 (up 90.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Schlumberger reported revenue of $30,440.00MM vs $27,810.00MM (up 9.46%) and basic earnings per share -$1.08 vs -$1.24. Schlumberger is expected to report earnings on July 20th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.35. The estimated EPS forecast for the next fiscal year is $2.92 and is expected to report on January 18th, 2019.
To read the full Schlumberger Limited (SLB) report, download it here: http://Fundamental-Markets.com/register/?so=SLB
-----------------------------------------
THERMO FISHER SCIENTIFIC INC. (TMO) REPORT OVERVIEW
Thermo Fisher Scientific's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Thermo Fisher Scientific reported revenue of $5,853.00MM vs $4,765.00MM (up 22.83%) and basic earnings per share $1.44 vs $1.41 (up 2.13%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Thermo Fisher Scientific reported revenue of $20,918.00MM vs $18,274.00MM (up 14.47%) and basic earnings per share $5.64 vs $5.12 (up 10.16%). Thermo Fisher Scientific is expected to report earnings on July 25th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $2.30. The estimated EPS forecast for the next fiscal year is $12.14 and is expected to report on January 30th, 2019.
To read the full Thermo Fisher Scientific Inc. (TMO) report, download it here: http://Fundamental-Markets.com/register/?so=TMO
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
